Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Bioceros - Pre-Clinical Development of Monoclonal Antibodies and Generation of GMP-Ready Proteins

Bioceros is one of Europe's premier providers of services in pre-clinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines.

Bioceros is one of Europe's premier providers of GMP-ready protein producing cell lines, based on our proprietary serum-free, suspension CHO platform (named CHOBC™). Bioceros' Cell Line Generation capabilities are underscored by its nomination by DSM and Crucell as the first pre-approved Europe-based PER.C6® cell line generation partner. All the Cell Line Generation work that we perform is Quality Controlled.

Blood proteins, monoclonal antibodies and fusion proteins

We have generated cell lines producing proteins ranging from blood proteins and monoclonal antibodies to fusion proteins. For monoclonal antibodies, our services start based on customers wishes, either with cDNA sequences to be expressed or by generation of antibodies in rodents, followed by cloning of the sequences from selected hybridomas. Further services include immunoassays, with a particular emphasis on cell based assays.

The people at Bioceros strongly believe that true and close collaboration speeds up selection and development of clients' most viable drug candidates. Therefore, the programs are designed in a flexible way, and scientists and staff involved in the programs are easily approachable. In addition, due to low overhead cost, our prices are very competitive.

Click here to see a presentation of Bioceros' hybrid business model for the production of monoclonal antibodies and other proteins.

Pre-clinical antibody development

Bioceros exploits its validated technology platform and its extensive pre-clinical antibody development expertise to select and develop novel functional effective proprietary therapeutic monoclonal antibodies.

Bioceros B.V.
Yalelaan 46
Alexander Numan Building, 2nd floor
3584 CM Utrecht
The Netherlands

www.bioceros.com
j.bia@bioceros.com
Tel: +31 30 253 89 55 or +31 6 3976 3445

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Request Further Information
Fill In Details

Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.
I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.
If you would prefer not to hear from carefully selected third party companies uncheck this box



By clicking the 'Request Information' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or letter. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory